Global Drug & Gene Delivery Systems Market Is Expected to Reach USD 815.6 Billion By 2030

The global drug & gene delivery systems market size was valued at USD 483.9 Billion in 2022 and is expected to reach USD 815.6 Billion by 2030, growing at a CAGR of 7.33% during the forecast period.

Drug and gene delivery systems are innovative technologies used to improve the efficacy and safety of drug therapies. These systems facilitate the targeted delivery of drugs and genes to specific cells or tissues, enhancing treatment outcomes and reducing side effects. Drug delivery systems include oral, injectable, inhalable, and transdermal delivery methods, while gene delivery systems use viral or non-viral vectors to deliver genetic material to cells. These systems are being increasingly used in the treatment of a wide range of diseases, including cancer, genetic disorders, and infectious diseases. Advancements in nanotechnology and biotechnology have enabled the development of more precise and personalized drug and gene delivery systems, further driving their adoption in clinical practice.

The global drug and gene delivery systems market is driven by the increasing prevalence of chronic diseases, advancements in nanotechnology, growing demand for non-invasive drug delivery methods, and a rise in biologics development. In addition, the market presents several opportunities such as the increasing focus on personalized medicine, the growing demand for self-administered drug delivery systems, and the adoption of digital health technologies.

These factors create ample opportunities for the drug and gene delivery systems industry. However, this market faces challenges such as the high cost of development & regulatory approval, the risk of adverse events, the need for better delivery technologies, the lack of standardization, and compatibility between different drug delivery systems. Addressing these challenges will be crucial for driving continued innovation and growth in the drug and gene delivery systems market, which is poised to continue growing as new technologies and applications emerge.

The global drug and gene delivery systems market is segmented based on delivery system, route of administration, application, and region.

Based on delivery system, the market is segmented into drug delivery system and gene delivery system segments. The drug delivery system segment held the largest market share in 2022 and is predicted to grow at a remarkable CAGR during the forecast period.

This growth can be attributed to several factors, including an increasing demand for targeted and personalized therapies, advancements in drug delivery technologies, and a rising prevalence of chronic diseases. Additionally, the growing trend towards the self-administration of drugs has increased demand for convenient and easy-to-use drug delivery systems, such as inhalers and transdermal patches. With the ongoing development of new drug delivery technologies and the continued focus on patient-centric healthcare, the drug delivery system segment is expected to continue its growth trajectory in the coming years.

Based on route of administration, the drug and gene delivery systems industry is segmented into oral, ocular, nasal, injectable, inhalation, transdermal, and topical. The oral segment held the largest market share in 2022 and is further predicted to grow rapidly at a significant CAGR during the forecast period. This growth can be attributed to several factors, including the convenience and ease of administration of oral drugs, the growing prevalence of chronic diseases that require long-term treatment, and the development of novel oral drug delivery technologies.

Additionally, the rising demand for patient-centric healthcare and personalized medicine has led to an increase in the development of oral drugs with targeted and specialized delivery systems. With ongoing advancements in technology and a focus on improving patient outcomes, the oral segment of the drug delivery systems market is expected to continue its growth in the future.

Based on application, the market is segmented into diabetes, central nervous system (CNS), infectious diseases, oncology, and others.

Based on region, the North American region held the largest drug and gene delivery systems market share in 2022 and is further predicted to grow at a notable CAGR during the forecast period. The global drug and gene delivery systems market has been growing steadily, with North America being a significant contributor to this growth. The market is driven by factors such as the increasing prevalence of chronic diseases, the aging population, and a growing demand for personalized and targeted therapies. The pharmaceutical and biotechnology industries in North America are among the largest in the world, and this has resulted in significant investment in research and development of new drug and gene delivery technologies. Furthermore, the region has a well-established regulatory framework, which has helped to streamline the development and approval process for new drugs and gene therapies.

In addition, the oral segment of the market has been experiencing strong growth in North America, with the development of new oral delivery technologies and the growing demand for patient-centric healthcare. With ongoing advancements in drug and gene delivery technologies and a continued focus on improving patient outcomes, the global drug and gene delivery systems market is expected to continue its growth trajectory in North America and across the globe.

Browse the full “Drug & Gene Delivery Systems Market By Delivery System (Drug Delivery Systems, Gene Delivery Systems), By Route Of Administration (Oral, Ocular, Nasal, Injectable, Inhalation, Transdermal, Topical), By Application (Diabetes, Central Nervous System (CNS), Infectious Diseases, Oncology, Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030.” Report at https://www.zionmarketresearch.com/report/drug-gene-delivery-systems-market

Recent Developments

• In September 2021, Pfizer and BioNTech announced positive results from a Phase 2/3 trial of their COVID-19 vaccine in children aged 5 to 11 years. The vaccine was found to be safe and effective, with a lower dosage than that given to adults. The companies plan to submit the data to regulatory authorities for emergency use authorization.
• In June 2021, Roche announced that it had received FDA approval for its intravitreal implant, which is used to treat neovascular (wet) age-related macular degeneration. The implant delivers a sustained release of the drug ranibizumab, reducing the need for frequent injections.

The global drug and gene delivery systems market is dominated by players such as:

• Pfizer
• Johnson & Johnson
• Novartis
• Roche
• Merck & Co.
• Sanofi
• GlaxoSmithKline
• AbbVie
• AstraZeneca
• Bayer
• Bristol-Myers Squibb
• Celgene
• Amgen
• Biogen
• Gilead Sciences
• Illumina
• Regeneron Pharmaceuticals
• Vertex Pharmaceuticals
• Moderna
• CRISPR Therapeutics
• Among Others.

The report segment of global drug & gene delivery systems market is as follows:

By Delivery System

• Drug Delivery Systems
• Gene Delivery Systems

By Route of Administration

• Oral
• Ocular
• Nasal
• Injectable
• Inhalation
• Transdermal
• Topical

By Application

• Diabetes
• CNS
• Infectious Diseases
• Oncology
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com